This link will take you to a Web site maintained by a third party who is solely responsible for its contents. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. provide this link as a service to Web site visitors. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. are not responsible for the privacy policy of any third party Web sites. We encourage you to read the privacy policy of every Web site you visit. Click CANCEL to return or OK to continue.

The information requested is intended for US healthcare professionals only.

The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe^® Acrobat^® Reader^®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

If you can read this, then your browser cannot interpret Javascript. To take full advantage of what this Web site has to offer, please make sure that you have Javascript enabled in your browser preferences, or update to a browser that supports Javascript. Thank you.

Home Investigators

Healthcare Professionals Patients and Caregivers

User Login

*Items with an asterisk are required.

Forgot Password?

The SUCCEED trial Web site is intended for US residents only. It is intended for Investigators, Healthcare Professionals, and Patients and Caregivers. The use of deforolimus (AP23573, MK-8669) is limited to investigational trials. There is no guarantee that its use will be approved by the US Food and Drug Administration.